Search

Your search keyword '"Gabriel Tobias"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Gabriel Tobias" Remove constraint Author: "Gabriel Tobias" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
29 results on '"Gabriel Tobias"'

Search Results

1. Secretome profiling reveals acute changes in oxidative stress, brain homeostasis, and coagulation following short-duration spaceflight

2. Outcome of Nellix-EVAS: single center mid-term results

Catalog

Books, media, physical & digital resources

6. The anaesthetic efficacy of Eucalyptus globulus essential oil on silver catfish (Rhamdia quelen).

7. Asymmetric Interplay Between K+ and Blocker and Atomistic Parameters From Physiological Experiments Quantify K+ Channel Blocker Release.

8. Chromium(II)-mediated Reformatsky reactions of carboxylic esters with aldehydes

10. Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1.

11. 3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: Design and development to a highly selective lead

12. Laser Cladding of Ultra-Thin Nickel-Based Superalloy Sheets.

13. Rye B chromosomes encode a functional Argonaute-like protein with in vitro slicer activities similar to its A chromosome paralog.

15. Vectorial photoinduced electron-transfer and charge separation in a Zu(II)-protoporphyrin-bipyridinium dyad reconstituted myoglobin

16. Assembly of a Zn(II)-porphyrin-bipyridinium dyad and Au-nanoparticle superstructures on conductive surfaces

17. Structure-Based Drug Designof RN486, a Potent andSelective Bruton’s Tyrosine Kinase (BTK) Inhibitor, for theTreatment of Rheumatoid Arthritis.

18. Discovery of 6-(2,4-Difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one (Pamapimod) and 6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (R1487) as...

25. Asymmetric Interplay Between K + and Blocker and Atomistic Parameters From Physiological Experiments Quantify K + Channel Blocker Release.

26. Extensive Embolization of Splanchnic Artery Aneurysms due to Segmental Arterial Mediolysis.

27. Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy.

28. Structure-based drug design of RN486, a potent and selective Bruton's tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritis.

29. Pathway to the clinic: inhibition of P38 MAP kinase. A review of ten chemotypes selected for development.